WASHINGTON (Reuters) – The United States, European Union, India and South Africa have reached a tentative agreement on a long-sought limited intellectual property waiver for COVID-19 vaccines, sources familiar with the deal said on Tuesday.
The tentative agreement among a narrower group of countries needs approvals from those parties’ capitals, the sources said, and would apply only to patents for COVID-19 vaccines – much narrower in scope than a broad World Trade Organization waiver backed by the United States.
(Reporting by David Lawder, Andrea Shalal, Emma Farge; Editing by Chris Reese)
